Correction to: Treatment of Tardive Dyskinesia: A General Overview with Focus on the Vesicular Monoamine Transporter 2 Inhibitors

Drugs. 2018 Apr;78(5):609. doi: 10.1007/s40265-018-0893-7.

Authors

Nicki Niemann¹, Joseph Jankovic²

Affiliations

¹ Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, 7200 Cambridge, Suite 9A, Houston, TX, 77030, USA.
² Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, 7200 Cambridge, Suite 9A, Houston, TX, 77030, USA. josephj@bcm.edu.

PMID: 29524074
DOI: 10.1007/s40265-018-0893-7

Abstract

The dose (mg/day) for Clonazepam which reads.

Publication types

Published Erratum